A Double-Blind, Placebo-Controlled, Phase 2 Trial of a Novel Toll-Like Receptor 7/8/9 Antagonist (IMO-8400) in Dermatomyositis Kim, Y., Schiopu, E., Danko, K., Mozaffar, T., Chunduru, S., Lees, K., Goyal, N., Fiorentino, D., Sarin, K. WILEY. 2019

View details for Web of Science ID 000507466905071